These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34665890)

  • 21. Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC).
    Bassir Nia A; Orejarena MJ; Flynn L; Luddy C; D'Souza DC; Skosnik PD; Pittman B; Ranganathan M
    Psychopharmacology (Berl); 2022 May; 239(5):1621-1628. PubMed ID: 35438304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
    Sugarman DE; Poling J; Sofuoglu M
    Pharmacol Biochem Behav; 2011 Mar; 98(1):94-100. PubMed ID: 21176784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC.
    Murray CH; Huang Z; Lee R; de Wit H
    Neuropsychopharmacology; 2022 Jun; 47(7):1331-1338. PubMed ID: 35110688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in the acute effects of oral and vaporized cannabis among healthy adults.
    Sholler DJ; Strickland JC; Spindle TR; Weerts EM; Vandrey R
    Addict Biol; 2021 Jul; 26(4):e12968. PubMed ID: 32985064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic nicotine exposure attenuates the effects of Δ
    Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
    Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis.
    Freeman AM; Mokrysz C; Hindocha C; Lawn W; Morgan CJ; Freeman TP; Saunders R; Curran HV
    J Psychopharmacol; 2021 Jul; 35(7):804-813. PubMed ID: 33427016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
    Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
    Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women.
    Wardle MC; Pabon E; Webber HE; de Wit H
    Psychopharmacology (Berl); 2022 May; 239(5):1487-1497. PubMed ID: 35102424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
    Drug Test Anal; 2016 Jul; 8(7):690-701. PubMed ID: 26257143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
    Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
    Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
    Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.
    Freeman D; Dunn G; Murray RM; Evans N; Lister R; Antley A; Slater M; Godlewska B; Cornish R; Williams J; Di Simplicio M; Igoumenou A; Brenneisen R; Tunbridge EM; Harrison PJ; Harmer CJ; Cowen P; Morrison PD
    Schizophr Bull; 2015 Mar; 41(2):391-9. PubMed ID: 25031222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.
    Bhattacharyya S; Iyegbe C; Atakan Z; Martin-Santos R; Crippa JA; Xu X; Williams S; Brammer M; Rubia K; Prata D; Collier DA; McGuire PK
    Psychol Med; 2014 Nov; 44(15):3315-28. PubMed ID: 25065544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resting sympathetic arousal moderates the association between parasympathetic reactivity and working memory performance in adults reporting high levels of life stress.
    Giuliano RJ; Gatzke-Kopp LM; Roos LE; Skowron EA
    Psychophysiology; 2017 Aug; 54(8):1195-1208. PubMed ID: 28449242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies.
    Ganesh S; Cortes-Briones J; Ranganathan M; Radhakrishnan R; Skosnik PD; D'Souza DC
    Int J Neuropsychopharmacol; 2020 Dec; 23(9):559-570. PubMed ID: 32385508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1977 Mar; 21(3):336-42. PubMed ID: 837652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids, interoception, and anxiety.
    Andrade AK; Renda B; Murray JE
    Pharmacol Biochem Behav; 2019 May; 180():60-73. PubMed ID: 30922834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.